Actemra Drug Tied to Significant Side Effects
Author: Parker Waichman LLP
Published: 2017/07/24 - Updated: 2023/09/20
Publication Type: Announcement / Notification
Topic: Pharmaceutical Information (Publications Database)
Page Content: Synopsis Introduction Main Item
Synopsis: Actemra, manufactured by Roche/Genentech, has been associated with heart attack, heart failure, stroke, pancreatitis, lung disease, gastrointestinal perforation, and more. An investigation conducted by Stat News revealed that hundreds of patients taking Actemra died from cardiovascular and pulmonary complications. According to the analysis, the U.S. Food and Drug Administration (FDA) received 1,128 reports of deaths in patients taking Actemra.
Introduction
Parker Waichman LLP, a national personal injury law firm dedicated to protecting the rights of victims injured by defective drugs, comments on investigation results involving the rheumatoid arthritis (RA) drug, Actemra (tocilizumab), which is manufactured by Roche/Genentech, revealed that hundreds of patient deaths were associated with the drug, according to a June 7, 2017, report.
Main Item
Actemra is approved to treat adults diagnosed with moderate to severe active RA. The drug was approved in 2010 and has been prescribed to more than 760,000 patients.
An investigation conducted by Stat News revealed that hundreds of patients taking Actemra died from cardiovascular and pulmonary complications, side effects not typically associated with the drug and that Actemra carried no warning labels concerning potential side effects.
Stat News indicated that it investigated more than 500,000 side effect reports for RA drugs and "found clear evidence" that the risk of the side effects such as heart attack or stroke, "were as high or higher for Actemra patients than for patients taking some competing drugs."
The difference, according to Stat News, is that Actemra, unlike the other RA drugs, does not carry a warning label for those side effects, reported PharmaLive.com
According to the analysis, the U.S. Food and Drug Administration (FDA) received 1,128 reports of deaths in patients taking Actemra; the FDA is unable to determine if Actemra was the direct cause of the deaths.
The Stat News report notes that;
"Though the agency is charged with monitoring the safety of prescription drugs, it doesn't verify the side-effect reports it receives."
Meanwhile, Stat News does cite a number of doctors' reports that suggest Actemra was significantly involved in the deaths of patients treated with Actemra. The doctors' comments about a suggested link between the deaths and Actemra were included; however, identities were not disclosed.
Stat News cited various experts who reviewed the analysis, concluding that the FDA must consider adding a warning label to Actemra for heart failure and pancreatitis.
According to PharmaLive.com, the experts also said that a failure to warn consumers "highlights the FDA's inability to adequately scrutinize the safety of drugs after they have been approved, and to act promptly when potential danger signs appear."
Attribution/Source(s):
This quality-reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by Parker Waichman LLP, and published on 2017/07/24 (Edit Update: 2023/09/20), the content may have been edited for style, clarity, or brevity. For further details or clarifications, Parker Waichman LLP can be contacted at yourlawyer.com. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
Explore Similar Topics
1 - How Propofol, an Anesthesia Drug, Induces Unconsciousness - Propofol, a widely used anesthetic, disrupts the brain's balance between stability and excitability.
2 - From Aspirin to Opioids: A Comprehensive Guide to Pain-Relieving Medications - Information on pain management medications, from common anti-inflammatory drugs to powerful prescription analgesics such as codeine and morphine, designed to address diverse levels of pain intensity.
3 - Can Pharmacological Treatment for ADHD Lower Criminal Behavior? - Pharmacological treatment of ADHD is commonly used in clinical practice, but the impact on crime remains debated.
Complete Publications Database
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Parker Waichman LLP. (2017, July 24 - Last revised: 2023, September 20). Actemra Drug Tied to Significant Side Effects. Disabled World. Retrieved November 7, 2024 from www.disabled-world.com/medical/pharmaceutical/ra-actemra.php
Permalink: <a href="https://www.disabled-world.com/medical/pharmaceutical/ra-actemra.php">Actemra Drug Tied to Significant Side Effects</a>: Actemra, manufactured by Roche/Genentech, has been associated with heart attack, heart failure, stroke, pancreatitis, lung disease, gastrointestinal perforation, and more.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.